medigraphic.com
Revista Médica Sinergia

2023, Number 03

<< Back Next >>

Revista Médica Sinergia 2023; 8 (03)

Overview of abnormal uterine bleeding: clinical evaluation and management

Hernández LA, Quiroz SCD, Rosales VM

Language: Spanish
References: 28
Page:
PDF size: 164.73 Kb.


ABSTRACT

Abnormal uterine bleeding (AUB) is a frequent reason for gynecological consultation due to its high incidence, which affects the quality of life of many women. In general terms, AUB is any bleeding of gynecological origin that presents abnormalities in its frequency, intensity or volume, which can have short, medium or long term consequences. According to its etiology it can be subdivided into two groupings, structural and non-structural (PALM-COEIN), this classification provides us with the facility in epidemiological research, understand the etiology and provide the optimal management, which should be personalized, the latter is divided into hormonal and nonhormonal treatment.


REFERENCES

  1. Côté I, Jacobs P, Cumming DC. Use of health services associated with increased menstrualloss in the United States. Am J Obstet Gynecol [Internet]. 2003;188(2):343–8.Disponible en:https://pubmed.ncbi.nlm.nih.gov/12592237/

  2. Franco R. Hemorragia uterina anormalorgánica. Revista Nacional de Itaguá.2012;4(2):15-22. Disponible a partir de:http://scielo.iics.una.py/pdf/hn/v4n2/v4n2a03.pdf

  3. Milman N, Clausen J, Byg KE. Iron status in268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation. AnnHematol [Internet]. 77(1-2):13-9. Disponible en:https://pubmed.ncbi.nlm.nih.gov/9760147/

  4. Hallberg L, Högdahl AM, Nilsson L, Rybo G.Menstrual blood loss--a population study. Variation at different ages and attempts todefine normality. Acta Obstet Gynecol Scand[Internet]. 45(3):320-51. Disponible en:https://pubmed.ncbi.nlm.nih.gov/5922481/

  5. Sepúlveda J, Sepúlveda A. Sangrado uterino anormal y PALM COEIN. Revista deGinecología y Obstetricia México. 2020;88(1):59-67. Recuperado a partir de:https://www.medigraphic.com/pdfs/ginobsmex/gom-2020/gom201j.pdf

  6. Sun Y, Wang Y, Mao L, Wen J, Bai W.Prevalence of abnormal uterine bleeding according to new International Federation ofGynecology and Obstetrics classification inChinese women of reproductive age: A cross-sectional study. Medicine (Baltimore) [Internet]. 2018;97(31):e11457. Disponible en:https://pubmed.ncbi.nlm.nih.gov/30075511/

  7. Hassa H, Tekin B, Senses T, Kaya M, KaratasA. Are the site, diameter, and number ofendometrial polyps related with symptomatology? Am J Obstet Gynecol [Internet]. 2006;194(3):718-21. Disponible en:https://pubmed.ncbi.nlm.nih.gov/16522403/

  8. Lee SC, Kaunitz AM, Sanchez-Ramos L,Rhatigan RM. The oncogenic potential ofendometrial polyps: a systematic review andmeta-analysis. Obstet Gynecol [Internet]. 2010 116(5):1197-205. Disponible en:https://pubmed.ncbi.nlm.nih.gov/20966706/

  9. Vigueras A, Escalona J. Póliposendometriales: Actualización en diagnóstico y tratamiento. Rev Chilena de Obstetricia y Ginecología. 2016;81(2):152-158. DOI: http://dx.doi.org/10.4067/S0717-75262016000200012

  10. 10.Levgur M. Diagnosis of adenomyosis: a review. J Reprod Med [Internet].2007;52(3):177-93. Disponible en:https://pubmed.ncbi.nlm.nih.gov/17465285/

  11. 11.Abbott JA. Adenomyosis and AbnormalUterine Bleeding (AUB-A)-Pathogenesis,diagnosis, and management. Best Pract Res Clin Obstet Gynaecol [Internet]. 2017;40:68-81. Disponible en:https://pubmed.ncbi.nlm.nih.gov/27810281/

  12. 12.Brun J, Fenomanana S, Pelage L, FernándezH. Adenomiosis: tratamiento. EMC-Ginecología- Obstetricia. 2015;51(3):1-10.Disponible a partir de:https://www.sciencedirect.com/science/article/abs/pii/S1283081X1572833

  13. Alfonso C. Leiomiomas uterinos e infertilidad. Sección de biología de la Universidad de laLaguna. 2019;1(1):1:27. Disponible a partir de:https://riull.ull.es/xmlui/bitstream/handle/915/15752/Leiomiomas%20uterinos%20e%20infertilidad.pdf?sequence=1

  14. 14.Lasmar RB, Lasmar BP. The role ofleiomyomas in the genesis of abnormaluterine bleeding (AUB). Best Pract Res ClinObstet Gynaecol [Internet]. 2017;40:82-8.Disponible en:https://pubmed.ncbi.nlm.nih.gov/27784616/

  15. Styer AK, Rueda BR. The epidemiology andgenetics of uterine leiomyoma. Best Pract Res Clin Obstet Gynaecol [Internet]. 2016;34:3-12. Disponible en:https://pubmed.ncbi.nlm.nih.gov/26725703/

  16. Emons G, Beckmann MW, Schmidt D, Mallmann P. Uterus commission of theGynecological Oncology Working Group(AGO). New WHO classification ofendometrial hyperplasias. Geburtshilfe Frauenheilkd [Internet]. 2015;75(2):135-6.Disponible en:https://pubmed.ncbi.nlm.nih.gov/25797956/

  17. Adams T, Denny L. Abnormal vaginalbleeding in women with gynecological malignancies. Best Pract Res Clin Obstet Gynaecol. 2017;40:134-47. DOI: https://doi.org/10.1016/j.bpobgyn.2016.09.014

  18. Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease inwomen with menorrhagia: a systematic review. BJOG [Internet]. 2004;111(7):734-40.Disponible en:https://pubmed.ncbi.nlm.nih.gov/15198765/

  19. Fuentes A, Castillo Z, Aragón J. Sangradouterino anormal (y endocrinológico). Revista de Endocrinología y Nutrición. 2005;13(1):39-46. Disponible a partir de:https://www.medigraphic.com/pdfs/endoc/er-2005/er051f.pdf

  20. Smith SK, Abel MH, Kelly RW, Baird DT. Prostaglandin synthesis in the endometriumof women with ovular dysfunctional uterine bleeding. BJOG [Internet].;88(4):434-42. DOI: http://dx.doi.org/10.1111/j.1471-0528.1981.tb01009.x

  21. Benetti-Pinto C, Rosa-e-Silva A, Yela D,Soares Júnior J. Abnormal Uterine Bleeding. Rev Bras Ginecol Obstet [Internet].2017;39(07):358–68. Disponible en:https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0037-1603807

  22. Chacón Campos N, Pizarro Madrigal M,Guerrero Hines C. Sangrado uterino anormalen etapa reproductiva. Rev Medica Sinerg [Internet]. 2022;7(5):e808. Disponible a partirde:https://revistamedicasinergia.com/index.php/rms/article/view/808

  23. Zurita G, Bravo E. Sangrado uterino anormal de origen no anatómico en mujeres enedades entre 15 a 50 años. Universidad Católica de Ecuador. 2017;1(1):1-104.Recuperado a partir de:http://repositorio.puce.edu.ec/bitstream/handle/22000/13279/ADAPTACION%20GUIA%20DE%20PRACTICA%20CLINICA%20SANGRADO%20UTERINO%20ANORMAL.pdf?sequence=1&isAllo%20wed=y

  24. Lee JY, Hahn PM, Van Dijk JP, Reid RL. Treatment of menorrhagia with tranexamic acid. J SOGC [Internet]. 2000;22(10):794–8.Disponible en:https://www.sciencedirect.com/science/article/pii/S0849583116310199

  25. Bonnar J, Sheppard BL. Treatment ofmenorrhagia during menstruation:randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ[Internet]. 313(7057):579–82. Disponible en:https://pubmed.ncbi.nlm.nih.gov/8806245/

  26. Bofill M, Lethaby A, Farquhar C. Non-steroidal anti-inflam-matory drugs for heavy menstrualbleeding. Cochrane Database Syst Rev. 2019;9(9):CD000400. Disponible en:https://pubmed.ncbi.nlm.nih.gov/31535715/

  27. Munro MG, Mainor N, Basu R, Brisinger M,Barreda L. Oral medroxyprogesteroneacetate and combination oral contraceptivesfor acute uterine bleeding: a randomized controlled trial: A randomized controlled trial. Obstet Gynecol [Internet]. 2006;108(4):924-9.Disponible en:https://pubmed.ncbi.nlm.nih.gov/17012455/

  28. Vega G, Bautista L, Rodríguez L, Loredo F,Vega J, Becerril A, et al. Frecuencia y factores asociados a la histerectomía obstétrica en unhospital de segundo nivel en México. Rev chilena de Obstetricia y Ginecología. 2017;82(5):526-533. Recuperado a partir de:https://scielo.conicyt.cl/scielo.php?pid=S0717-75262017000500526&script=sci_arttext&tlng=n




2020     |     www.medigraphic.com